WHY WE HAVE A NEW NAME
Today we officially announce that Cambridge Bio-Augmentation Systems (CBAS) has become BIOS Health.
As we grow as a team, expand our capacity, and become increasingly global, we are looking to the future of our company and this new name more accurately reflects the incredibly exciting developments ahead of us.
We are bringing the first open standard neural interfaces into widespread use and have started to drive a global ecosystem of change in neural engineering. As we continue to accelerate and create the standards, datasets, tools, and algorithms for the future of neural interfaces, we are thrilled to have found a name that suits our company ethos and helps communicate the benefits and potential of our products and technology.
While we continue to focus on an ever deeper, higher fidelity and longer lasting integration between our bodies and machines; we invite you to start to use these tools to show us what can be done.
The BIOS Health team
About BIOS Health
BIOS is unlocking the potential of the nervous system in treating chronic disease by using AI-powered neural interfaces that can automatically read and write neural signals. The human nervous system carries vast quantities of data and scientists have long known that faulty signals in the nervous system play a key role in driving chronic diseases. By understanding and correcting these signals in real time, BIOS can treat chronic illnesses in an effective, automated, and personalised way. BIOS has leveraged recent breakthroughs in AI and Machine Learning to translate the “language” of the nervous system for the first time. BIOS’ neural code is built on the world’s largest proprietary neural data set and is already in use clinically to enhance data from wearables used in remote chronic disease care.
Co-founded by Cambridge University graduates Emil Hewage, a computational neuroscientist, and Oliver Armitage, a biomechanical engineer, BIOS is made up of a wide range of experts from neuroscience, machine learning, software engineering, applied biomaterials, biotechnology, and medicine. The combined experience of the BIOS team extends to over 300 peer-reviewed publications, 10+ First of kind medical devices and 6k+ clinical procedures.
Head of Communications